indicated during the convalescence and residual phase of poliomyelitis; in neuritis, radiculitis, polyneuritis; spastic paresis and paralysis; myopathy, myasthenia gravis, progressive muscular dystrophy; infantile cerebral paralysis, birth paralysis, nocturnal enuresis, residual paresis following a cerebral hemorrhage, and for elimination of the effect of nondepolarizing neuromuscular blockers. As an antidote in poisoning with Morphinum hydrochloricum. Mild to moderate dementia of Alzheimer's type (tablets).